The Valley Desk

Clinical trial reportJournal of comparative effectiveness researchPublished

Polymer-based drug-eluting stent treatment extends the time to reintervention for patients with symptomatic femoropopliteal artery disease: clinical evidence and potential economic value

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Main Line Health, Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of comparative effectiveness research
Published
Subject terms
Femoral Artery; Popliteal Artery; Humans; Alloys; Paclitaxel; Polymers; Time Factors; Aged; Middle Aged; Cost-Benefit Analysis; Cost Savings; Female
PubMed ID
38606556
PubMed Central ID
PMC11145520
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal